Ramcirumab In Promega Vegf Assay
Lab Reagents
Human IgG antibody Laboratories manufactures the ramcirumab in promega vegf assay reagents distributed by Genprice. The Ramcirumab In Promega Vegf Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact vegf assay. Other Ramcirumab products are available in stock. Specificity: Ramcirumab Category: In Group: Promega Vegf
Mouse Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
| RDR-EG-VEGF-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 618 |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
| RDR-EG-VEGF-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 470 |
Rat Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) ELISA Kit |
|||
| RDR-EG-VEGF-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 651 |
VEGF |
|||
| MO15067 | Neuromics | 500 ug | EUR 910 |
VEGF |
|||
| PR15028 | Neuromics | 10 ug | EUR 461 |
VEGF |
|||
| LF-PR009 | Abfrontier | 10 ug | EUR 255 |
|
Description: VEGF protein |
|||
Endothelial Tube Formation Assay (In Vitro Angiogenesis Assay) |
|||
| CBA-200 | Cell Biolabs | 50 assays | EUR 560 |
|
Description: For angiogenesis to occur, endothelial cells must escape their stable location and break through the basement membrane. Cells migrate toward an angiogenic stimulus that may be released from nearby tumor cells. These cells proliferate to form new blood vessels. Our Endothelial Tube Formation Assay (In Vitro Angiogenesis) provides an easy, robust system to assess angiogenesis in vitro. The ECM gel matrix very closely resembles an in vivo environment. |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC041063-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC041063-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC471063-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC471063-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF647 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCAP1063-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNCAP1063-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC811063-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC811063-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC701063-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
|||
VEGF-A(VEGF/1063) Antibody |
|||
| BNC701063-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL |
|||